ArticleInternational journal of medical sciences2012

THRB genetic polymorphisms can predict severe myelotoxicity after definitive chemoradiotherapy in patients with esophageal squamous cell carcinoma.

Ikuya Miki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.